Results 261 to 270 of about 1,125,014 (336)
NEU1, a key regulator of glycolysis, is markedly upregulated following DOX treatment. This upregulation is attributed to HIF1α’s transcriptional repression, requiring intricate interactions with NRF2. Increased NEU1 facilitates SIRT1 lysosomal degradation, contributing to aberrant glycolytic phenotype and cardiac damage.
Ting Gao+13 more
wiley +1 more source
The molecular pathogenesis of SOX2 in prostate cancer. [PDF]
Liu S, Yu H, Zhao Z.
europepmc +1 more source
MYC is a transcription factor (TF) that binds DNA near transcriptional start sites (TSSs) and within enhancer elements. Here, unappreciated sites of MYC binding in the vicinity of transcriptional end sites (TESs) of many genes in multiple cell types in association with numerous other TFs are described previously.
Huabo Wang+5 more
wiley +1 more source
Immunomodulation and Immunotherapy for Patients with Prostate Cancer: An Up-to-Date Review. [PDF]
Murray NP.
europepmc +1 more source
Rectal examination for early detection of prostatic cancer.
YOHJI KATSUOKA
openalex +2 more sources
Based on IP‐MS analysis, BAG2 is confirmed to be essential for ubiquitination and protein homeostasis regulation of STING in cervical cancer. BAG2 inhibits the ubiquitination and degradation of STING by forming a complex with STUB1, thereby activating the type I IFN signaling pathway and inhibiting the development of cervical cancer.
Shijie Yao+6 more
wiley +1 more source
Prostate Cancer: genetics in practice now and in the future. [PDF]
McHugh J+3 more
europepmc +1 more source
PROGNOSTIC EVALUATION OF PROSTATIC CANCER BY GLEASON'S HISTOPATHOLOGIC GRADING AND TISSUE DHT LEVEL
Yoshiteru Kohama+6 more
openalex +2 more sources
The study identifies a novel circular RNA derived from the TP53 gene (circTP53), which is upregulated in HNSCC and correlates with poor patient prognosis. It demonstrates that circTP53 promotes HNSCC progression by interacting with USP10, stabilizing both proteins, enhancing deubiquitination of p53, and thereby influencing tumor growth, with its ...
Yin Wang+11 more
wiley +1 more source
Immunotherapy in Prostate Cancer: From a "Cold" Tumor to a "Hot" Prospect. [PDF]
Kwon WA, Joung JY.
europepmc +1 more source